Evidence map›Paper›PMID 35166689›Full record

ArticleJournal of medical Internet research2022

Building a Precision Medicine Delivery Platform for Clinics: The University of California, San Francisco, BRIDGE Experience.

Riley Bove, Erica Schleimer, Paul Sukhanov, Michael Gilson, Sindy M Law, Andrew Barnecut, Bruce L Miller, Stephen L Hauser, Stephan J Sanders, Katherine P Rankin

Abstract read
In one paragraph

Article in Journal of medical Internet research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Actionable Wearables Data for the Neurology Clinic: A Proof-of-Concept Tool.Annals of clinical and translational neurology · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Riley Bove *UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, United States.ORCID 0000-0002-2034-8800
Erica Schleimer *UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, United States.ORCID 0000-0001-5040-6306
Paul SukhanovUCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, United States.ORCID 0000-0002-1811-2620
Michael GilsonUCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, United States.ORCID 0000-0003-0883-7000
Sindy M LawUCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, United States.ORCID 0000-0001-7036-1774
Andrew BarnecutUCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, United States.ORCID 0000-0003-1003-272X
Bruce L MillerUCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, United States.ORCID 0000-0002-2152-4220
Stephen L HauserUCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, United States.ORCID 0000-0002-4932-4001
Stephan J Sanders *UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, United States.ORCID 0000-0001-9112-5148
Katherine P Rankin *UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, United States.ORCID 0000-0002-3611-0848

Funding

The Role of B cells in the Origin and Progression of Multiple SclerosisR35NS111644 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEPHEN L HAUSER · 2019 to 2026
$9.1M
NINDS NIH HHS R35 NS111644
6 · The paper itself

Abstract

Despite an ever-expanding number of analytics with the potential to impact clinical care, the field currently lacks point-of-care technological tools that allow clinicians to efficiently select disease-relevant data about their patients, algorithmically derive clinical indices (eg, risk scores), and view these data in straightforward graphical formats to inform real-time clinical decisions. Thus far, solutions to this problem have relied on either bottom-up approaches that are limited to a single clinic or generic top-down approaches that do not address clinical users' specific setting-relevant or disease-relevant needs. As a road map for developing similar platforms, we describe our experience with building a custom but institution-wide platform that enables economies of time, cost, and expertise. The BRIDGE platform was designed to be modular and scalable and was customized to data types relevant to given clinical contexts within a major university medical center. The development process occurred by using a series of human-centered design phases with extensive, consistent stakeholder input. This institution-wide approach yielded a unified, carefully regulated, cross-specialty clinical research platform that can be launched during a patient's electronic health record encounter. The platform pulls clinical data from the electronic health record (Epic; Epic Systems) as well as other clinical and research sources in real time; analyzes the combined data to derive clinical indices; and displays them in simple, clinician-designed visual formats specific to each disorder and clinic. By integrating an application into the clinical workflow and allowing clinicians to access data sources that would otherwise be cumbersome to assemble, view, and manipulate, institution-wide platforms represent an alternative approach to achieving the vision of true personalized medicine.

Indexed as

Electronic Health RecordsPrecision MedicineHumansSan FranciscoSoftwareanalysisanalyticclinical dashboardclinical implementationdashboarddecision-makingdesignexperiencehuman-centered designimplementationin silico trialsplatformprecisionprecision medicinereal timetool

Identifiers

PMID35166689
PMCPMC8889486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.